Strategic partnerships Tebubio has a track record of rapidly expanding its European footprint through strategic partnerships with leading biotech suppliers and service providers, creating multiple access points for a broader product and solution portfolio that can be leveraged in co-selling and channel initiatives.

Integrated offerings The company combines life sciences reagents, contract research services (mRNA production, cell line engineering, biomarker analysis), and streamlined e-procurement, enabling cross-sell opportunities to researchers seeking end-to-end support and time-saving procurement.

CAR-T and beyond Recent partnerships with ProMab Biotechnologies and TriLink BioTechnologies position Tebubio as a gateway to advanced cell therapy tools, ready-to-use CAR constructs, mRNA technologies, and off-the-shelf capabilities suitable for buyers accelerating immunotherapy projects.

3D culture leadership Access to TheWell Bioscience RocketCell xeno-free media and hydrogel systems highlights Tebubio’s strength in scalable 3D culture for iPSCs and organoids, presenting cross-sell potential to labs expanding into organoid models and regenerative research.

Expansion signals Continuous European expansion and a broad supplier ecosystem provide sales potential to offer localized support, regulatory-compliant purchasing, and diversified product lines to researchers facing procurement bottlenecks and compliance concerns.